Evidence map›Paper›PMID 41094847›Full record

ReviewSensors (Basel, Switzerland)2025

Field Explosives Detectors-Current Status and Development Prospects.

Dariusz Augustyniak, Mateusz Szala

Abstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dariusz AugustyniakFaculty of New Technologies and Chemistry, Department of Explosives, Military University of Technology, S. Kaliskiego 2, 00-908 Warsaw, Poland.ORCID 0009-0003-1191-3091
Mateusz SzalaFaculty of New Technologies and Chemistry, Department of Explosives, Military University of Technology, S. Kaliskiego 2, 00-908 Warsaw, Poland.ORCID 0000-0002-6928-2689

Funding

Polish Ministry of Science and Higher Education RID/SP/0042/2024/01
6 · The paper itself

Abstract

This review critically evaluates the performance of approximately 80 commercially available mobile detectors for explosive identification. The majority of devices utilize Ion Mobility Spectrometry (IMS), Fourier Transform Infrared Spectroscopy (FTIR), or Raman Spectroscopy (RS). IMS-based instruments, such as the M-ION (Inward Detection), typically achieve sensitivities at the ppt level, while other IMS implementations demonstrate detection ranges from low ppb to ppm. Gas Chromatography-Mass Spectrometry (GC-MS) systems, represented by the Griffin™ G510 (Teledyne FLIR Detection), provide detection limits in the ppb range. Transportable Mass Spectrometers (Bay Spec) operate at ppb to ppt levels, whereas Laser-Induced Fluorescence (LIF) devices, such as the Fido X4 (Teledyne FLIR Detection), achieve detection at the nanogram level. Quartz Crystal Microbalance (QCM) sensors, exemplified by the EXPLOSCAN (MS Technologies Inc. 8609 Westwood Center Drive Suite 110, Tysons Corner, VA, USA), typically reach the ppb range. Only four devices employ two orthogonal analytical techniques, enhancing detection reliability and reducing false alarms. Traditional colorimetric tests based on reagent-analyte reactions remain in use, demonstrating the continued relevance of simple yet effective methods. By analyzing the capabilities, limitations, and technological trends of current detection systems, this study underscores the importance of multi-technique approaches to improve accuracy, efficiency, and operational effectiveness in real-world applications. The findings provide guidance for the development and selection of mobile detection technologies for security, defense, and emergency response.

Indexed as

analysisdetectiondetectorsexplosivesfield detectors

Identifiers

PMID41094847
PMCPMC12526599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.